SCHEMBL6994097

SCHEMBL6994097

CC(C)(C)OC(=O)NCCCc1cccnc1Br

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
KDM4E B2RXH2 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NQO2 P16083 1/20 0.45
CA1 P00915 5/20 0.44
CA2 P00918 5/20 0.44
CA12 O43570 4/20 0.44
CA9 Q16790 4/20 0.44
TDP1 Q9NUW8 2/20 0.43
STK17B O94768 1/20 0.42
STK17A Q9UEE5 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GAA P10253 1/20 0.42
IDO1 P14902 1/20 0.41
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 1/20 0.40
PDPK1 O15530 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991507 0.86 KDM4E (0.48) CYP3A4KDM4EL3MBTL1NQO2CA1
SCHEMBL17018589 0.84 NAMPT (0.46) CYP3A4KDM4EL3MBTL1NQO2LMNA
SCHEMBL35210561 0.84 NAMPT (0.46) CYP3A4KDM4EL3MBTL1NQO2LMNA
SCHEMBL23177724 0.83 CA1 (0.47) CYP3A4KDM4EL3MBTL1NQO2CA1
SCHEMBL28881731 0.82 CYP3A4 (0.44) CYP3A4KDM4EL3MBTL1NQO2CA1
SCHEMBL20140791 0.82 CTSS (0.50) NQO2CA1CA2CA12CA9
SCHEMBL12667243 0.81 TDP1 (0.46) CYP3A4KDM4EL3MBTL1NQO2CA1
SCHEMBL21794713 0.78 TDP1 (0.50) NQO2CA1CA2CA12CA9
SCHEMBL6554649 0.78 NQO2 (0.56) CYP3A4KDM4EL3MBTL1NQO2CA1
SCHEMBL25056476 0.78 KDM4E (0.45) CYP3A4KDM4EL3MBTL1NQO2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303488-A1 PIPERIDINE COMPOUNDS FOR USE AS CCR-3 INHIBITORS Novartis AG (CH) 2003-04-23 EP disclosed
WO-2002004420-A1 PIPERIDINE COUMPOUNDS FOR USE AS CCR-3 INHIBITORS NOVARTIS AG (CH) 2002-01-17 WO disclosed